Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Pielenhofer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 17, 2020
Current Progress in Particle-Based Systems for Transdermal Vaccine DeliveryJonas Pielenhofer, Julian Sohl, Maike Windbergs, et al.
Drug Metabolism and Pharmacokinetics|February 22, 2023
Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucusMauricio A García, Gönül Hensler, Jozef Al-Gousous, et al.
Frontiers in Drug Delivery|August 21, 2025
Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimodSophie Luise Meiser, Jonas Pielenhofer, Ann-Kathrin Hartmann, et al.
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Pharmaceutics|February 25, 2023
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductJonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, et al.
Frontiers in Immunology|October 18, 2023
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapyJoschka Bartneck, Ann-Kathrin Hartmann, Lara Stein, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 17, 2020
Current Progress in Particle-Based Systems for Transdermal Vaccine DeliveryJonas Pielenhofer, Julian Sohl, Maike Windbergs, et al.
Drug Metabolism and Pharmacokinetics|February 22, 2023
Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucusMauricio A García, Gönül Hensler, Jozef Al-Gousous, et al.
Frontiers in Drug Delivery|August 21, 2025
Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimodSophie Luise Meiser, Jonas Pielenhofer, Ann-Kathrin Hartmann, et al.
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Pharmaceutics|February 25, 2023
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductJonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, et al.
Frontiers in Immunology|October 18, 2023
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapyJoschka Bartneck, Ann-Kathrin Hartmann, Lara Stein, et al.
Pageof 1